Chronic Low Back Pain Clinical Trial
— E-lombactifsOfficial title:
E-lombactifs: Evaluation of the Impact a Smartphone Application on Adherence an Exercise Program in Chronic Low Back Pain
Verified date | February 2024 |
Source | University Hospital, Clermont-Ferrand |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main objective is to assess the impact of smartphone application on adherence to a physical exercise program in chronic low back pain patients. Adherence to a physical exercise program will be assessed at the start of the protocol, at three weeks and six months. A control group will benefit from conventional care in a rehabilitation center and an intervention group will benefit from a conventional care in a rehabilitation center accompanied by education in the use of a smartphone application including physical exercises and information about low back pain. The hypothesis of the search is that adherence is better in intervention group than control group at 6 months due to education in the use of smartphone application.
Status | Completed |
Enrollment | 120 |
Est. completion date | December 18, 2023 |
Est. primary completion date | December 18, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult People - With nonspecific chronic low back pain (according to the definition of the HAS) - Covered under the national health insurance - Giving informed written consent to participate in the study Exclusion Criteria: - Patient who do not meet the diagnostic criteria according to the definition of HAS - Behavioral disorders or comprehension difficulties making assessment impossible - Patient with a contraindication to physical exercise for medical reasons - Patient under guardianship, curatorship or safeguard of justice |
Country | Name | City | State |
---|---|---|---|
France | Chu Clermont Ferrand | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | EARS : exercise adherence rating scale | EARS assess the adherence in physical activity program. | day1 | |
Primary | EARS : exercise adherence rating scale | EARS assess the adherence in physical activity program. | day 15 | |
Primary | EARS : exercise adherence rating scale | EARS assess the adherence in physical activity program. | day 180 | |
Secondary | OSWESTRY questionnaire | Disability is measured by OSWESTRY | day1, day 15, day 180 | |
Secondary | EPAP questionnaire | The perceived barriers to and facilitators of physical activity are measured by EPAP | day1, day 15, day 180 | |
Secondary | Pain measurment: numeric scale | The pain is measured by numeric scale | day1, day 15, day 180 | |
Secondary | 6 minutes' walk test (6MWT) | Aerobic and functional capacities are measured by 6 minutes' walk test (6MWT) | day1, day 15, day 180 | |
Secondary | aerobic capacities | aerobic capacities are measured by sub maximal ergocycle test | day1, day 15, day 180 | |
Secondary | muscular endurance | the muscular endurance of the erector muscles of the spine is measured by Sorensen test | day1, day 15, day 180 | |
Secondary | muscular endurance of the flexor muscles of the spine | the muscular endurance of the flexor muscles of the spine is measured by ITO test | day1, day 15, day 180 | |
Secondary | muscular endurance of the extensor of the knee | the muscular endurance of the extensor of the knee is measured by Killy test | day1, day 15, day 180 | |
Secondary | Core measurment | Core is measured by plank test | day1, day 15, day 180 | |
Secondary | Flexibility on posterior chain | Flexibility on posterior chain is measured by DDS test | day1, day 15, day 180 | |
Secondary | Mobility on posterior chain | Mobility on posterior chain is measured by Schober test | day1, day 15, day 180 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |